Literature DB >> 15644217

Functional solubilization of aggregation-prone HIV envelope proteins by covalent fusion with chaperone modules.

Christian Scholz1, Peter Schaarschmidt, Alfred Michael Engel, Herbert Andres, Urban Schmitt, Elke Faatz, Jochen Balbach, Franz Xaver Schmid.   

Abstract

The envelope proteins of human immunodeficiency virus (HIV) and human T-cell lymphotrophic virus (HTLV) mediate cell attachment and membrane fusion. For HIV-1, the precursor protein gp160 is cleaved proteolytically into two fragments, the surface-associated receptor binding subunit gp120 and the membrane spanning subunit gp41, which is involved in membrane fusion during virus entry. Soluble and immunoreactive variants of gp41 are essential for the reliable diagnosis of HIV-1 infections. Hitherto, gp41 was solubilized by adding detergents, or in acidic or alkaline solvents. We find that covalent fusions with SlyD or FkpA, two homodimeric Escherichia coli chaperones with peptidyl-prolyl isomerase activity, solubilize retroviral envelope proteins without compromising their immunological reactivity. gp41 from HIV-1, gp36 from HIV-2 and gp21 from HTLV could be expressed in large amounts in the Escherichia coli cytosol when fused with one or two subunits of SlyD or FkpA. The fusion proteins could be easily isolated and refolded, and showed high solubility and immunoreactivity, thus providing sensitive and reliable tools for diagnostic applications. Covalent fusions with SlyD or FkpA might be valuable generic tools for the solubilization and activation of aggregation-prone proteins.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15644217     DOI: 10.1016/j.jmb.2004.10.091

Source DB:  PubMed          Journal:  J Mol Biol        ISSN: 0022-2836            Impact factor:   5.469


  12 in total

Review 1.  Spatial cycles in G-protein crowd control.

Authors:  Nachiket Vartak; Philippe Bastiaens
Journal:  EMBO J       Date:  2010-08-18       Impact factor: 11.598

2.  Immunogenicity of recombinant human immunodeficiency virus type 1-like particles expressing gp41 derivatives in a pre-fusion state.

Authors:  Mikyung Kim; Zhisong Qiao; Jessica Yu; David Montefiori; Ellis L Reinherz
Journal:  Vaccine       Date:  2006-10-09       Impact factor: 3.641

3.  Designing a soluble near full-length HIV-1 gp41 trimer.

Authors:  Guofen Gao; Lindsay Wieczorek; Kristina K Peachman; Victoria R Polonis; Carl R Alving; Mangala Rao; Venigalla B Rao
Journal:  J Biol Chem       Date:  2012-11-26       Impact factor: 5.157

4.  Molecular and Physicochemical Factors Governing Solubility of the HIV gp41 Ectodomain.

Authors:  Fadia Manssour-Triedo; Sara Crespillo; Bertrand Morel; Salvador Casares; Pedro L Mateo; Frank Notka; Marie G Roger; Nicolas Mouz; Raphaelle El-Habib; Francisco Conejero-Lara
Journal:  Biophys J       Date:  2016-08-23       Impact factor: 4.033

5.  Enhanced HIV SOSIP Envelope yields in plants through transient co-expression of peptidyl-prolyl isomerase B and calreticulin chaperones and ER targeting.

Authors:  Yvonne J Rosenberg; Xiaoming Jiang; Jonathan P Lees; Lori A Urban; Lingjun Mao; Markus Sack
Journal:  Sci Rep       Date:  2022-06-15       Impact factor: 4.996

6.  Characterization of recombinantly expressed matrilin VWA domains.

Authors:  Ann-Kathrin A Becker; Halina Mikolajek; Jörn M Werner; Mats Paulsson; Raimund Wagener
Journal:  Protein Expr Purif       Date:  2014-11-21       Impact factor: 1.650

7.  Discovery of a microbial transglutaminase enabling highly site-specific labeling of proteins.

Authors:  Wojtek Steffen; Fu Chong Ko; Jigar Patel; Victor Lyamichev; Thomas J Albert; Jörg Benz; Markus G Rudolph; Frank Bergmann; Thomas Streidl; Peter Kratzsch; Mara Boenitz-Dulat; Tobias Oelschlaegel; Michael Schraeml
Journal:  J Biol Chem       Date:  2017-07-27       Impact factor: 5.157

8.  DNA Vaccine-Encoded Flagellin Can Be Used as an Adjuvant Scaffold to Augment HIV-1 gp41 Membrane Proximal External Region Immunogenicity.

Authors:  Lara Ajamian; Luca Melnychuk; Patrick Jean-Pierre; Gerasimos J Zaharatos
Journal:  Viruses       Date:  2018-02-27       Impact factor: 5.048

9.  Assessment of antibody responses against gp41 in HIV-1-infected patients using soluble gp41 fusion proteins and peptides derived from M group consensus envelope.

Authors:  Adam Penn-Nicholson; Dong P Han; Soon J Kim; Hanna Park; Rais Ansari; David C Montefiori; Michael W Cho
Journal:  Virology       Date:  2007-12-19       Impact factor: 3.616

10.  Maltose-Binding Protein (MBP), a Secretion-Enhancing Tag for Mammalian Protein Expression Systems.

Authors:  Raphael Reuten; Denise Nikodemus; Maria B Oliveira; Trushar R Patel; Bent Brachvogel; Isabelle Breloy; Jörg Stetefeld; Manuel Koch
Journal:  PLoS One       Date:  2016-03-30       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.